A novel muscle-specific enhancer identified within the deletion overlap region of two XLDC patients lacking muscle exon 1 of the human dystrophin gene

Genomics

Volumn 80, Issue 6, 2002, Pages 614-620

  Bastianutto, Carlo ^a   De Visser, Marianne ^b   Muntoni, Francesco ^c   Klamut, Henry J ^a   Patarnello, Tomaso ^d  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Imperial College of Medicine   (United Kingdom)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Dystrophin; Enhancer elements; Muscle gene regulation; X linked dilated cardiomyopathy

Indexed keywords

DYSTROPHIN; DYSTROPHIN MUSCLE ENHANCER 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; ENHANCER REGION; EXON; FIBROBLAST; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HEART DILATATION; HEART MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; SEQUENCE ANALYSIS;

ANIMALIA;

EID: 12244302491     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.2002.7015     Document Type: Article

References (44)

1. Hoffman, E. P., Brown, R. H., Jr., and Kunkel, L. M. (1987). Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928.
2. Hoffman, E. P., Knudson, C. M., Campbell, K. P., and Kunkel, L. M. (1987). Subcellular fractionation of dystrophin to the triads of skeletal muscle. Nature 330: 754-758.
3. Monaco, A. P. (1989). Dystrophin, the protein product of the Duchenne/Becker muscular dystrophy gene. Trends Biochem. Sci. 14: 412-415.
4. Koenig, M., Monaco, A. P., and Kunkel, L. M. (1988). The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53: 219-226.
5. Nudel, U., et al. (1989). Duchenne muscular dystrophy gene product is not identical in mouse and brain. Nature 337: 76-78.
6. Boyce, F. M., Beggs, A. H., Feener, C., and Kunkel, L. M. (1991). Dystrophin is transcribed in brain from a distant upstream promoter. Proc. Natl. Acad. Sci. USA 88: 1276-1280.
7. Gorecki, D. C., et al. (1992). Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum. Mol. Genet. 1: 505-510.
8. Holder, E., Maeda, M., and Bies, R. D. (1996). Expression and regulation of the dystrophin Purkinje promoter in human skeletal muscle, heart, and brain. Hum. Genet. 97: 232-239.
9. Abdulrazzak, H., et al. (2001). Structural diversity despite strong evolutionary conservation in the 5′-untranslated region of the p-type dystrophin transcript. Mol. Cell. Neurosci. 17: 500-513.
10. Emery, A. E. H. (1993). Duchenne Muscular Dystrophy. Oxford Univ. Press, New York.
11. Berko, B. A., and Swift, M. (1987). X-linked dilated cardiomyopathy. N. Engl. J. Med. 316: 1186-1191.
12. Towbin, J. A., et al. (1993). X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 87: 1854-1865.
13. Muntoni, F., et al. (1993). Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N. Engl. J. Med. 329: 921-925.
14. Yoshida, K., et al. (1993). Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy. Muscle Nerve 16: 1161-1166.
15. Yoshida, K., Nakamura, A., Yazaki, M., Ikeda, S., and Takeda, S. (1998). Insertional mutation by transposable element, L1, in the DMD gene results in X-linked dilated cardiomyopathy. Hum. Mol. Genet. 7: 1129-1132.
16. Milasin, J., et al. (1996). A point mutation in the 5′ splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum. Mol. Genet. 5: 73-79.
17. Bastianutto, C., et al. (2001). Dystrophin muscle enhancer 1 is implicated in the activation of non-muscle isoforms in the skeletal muscle of patients with X-linked dilated cardiomyopathy. Hum. Mol. Genet. 10: 2627-2635.
18. Nakamura, A., et al. (1997). Up-regulation of the brain and Purkinje-cell forms of dystrophin transcripts, in Becker muscular dystrophy. Am. J. Hum. Genet. 60: 1555-1558. [Letter]
19. Muntoni, F., Melis, M. A., Ganau, A., and Dubowitz, V. (1995). Transcription of the gene in normal tissues and in skeletal muscle of a family with X-linked dilated cardiomyopathy. Am. J. Hum. Genet. 56: 151-157.
20. Muntoni, F., et al. (1995). A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. J. Clin. Invest. 96: 693-699.
21. Klamut, H. J., Gangopadhyay, S. B., Worton, R. G., and Ray, P. N. (1990). Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene. Mol. Cell. Biol. 10: 193-205.
22. Gilgenkrantz, H., et al. (1992). Positive and negative regulatory DNA elements including a CCArGG box are involved in the cell type-specific expression of the human muscle dystrophin gene. J. Biol. Chem. 267: 10823-10830.
23. Kimura, S., et al. (1997). A 900 bp genomic region from the mouse dystrophin promoter directs lacZ reporter expression only in the right heart of transgenic mice. Dev. Growth Differ. 39: 257-265.
24. Ogawa, M., et al. (2001). The lacZ gene under the control of the 7 kb of human dystrophin muscle specific promoter is expressed in cardiac muscle but not in adult skeletal muscle in transgenic mice. Neuromusc. Disord. 11: 244-250.
25. Heinemeyer, T., et al. (1998). Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26: 362-367.
26. Gossett, L. A., Kelvin, D. J., Sternberg, E. A., and Olson, E. N. (1989). A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol. Cell. Biol. 9: 5022-5033.
27. Cserjesi, P., and Olson, E. N. (1991). Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products. Mol. Cell. Biol. 11: 4854-4862.
28. Funk, W. D., and Wright, W. E. (1992). Cyclic amplification and selection of targets for multicomponent complexes: Myogenin interacts with factors recognizing binding sites for basic helix-loop-helix, nuclear factor 1, myocyte-specific enhancer-binding factor 2, and COMP1 factor. Proc. Natl. Acad. Sci. U.S.A. 89: 9484-9488.
29. Muscat, G. E., Gustafson, T. A., and Kedes, L. (1988). A common factor regulates skeletal and cardiac alpha-actin gene transcription in muscle. Mol. Cell. Biol. 8: 4120-4133.
30. Boxer, L. M., Miwa, T., Gustafson, T. A., and Kedes, L. (1989). Identification and characterization of a factor that binds to two human sarcomeric actin promoters. J. Biol. Chem. 264: 1284-1292.
31. Gustafson, T. A., and Kedes, L. (1989). Identification of multiple proteins that interact with functional regions of the human cardiac alpha-actin promoter. Mol. Cell. Biol. 9: 3269-3283.
32. Lassar, A. B., et al. (1989). MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell 58: 823-831.
33. Blackwell, T. K., and Weintraub, H. (1990). Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250: 1104-1110.
34. Chen, C. Y., and Schwartz, R. J. (1995). Identification of novel DNA binding targets and regulatory domains of a murine tinman homeodomain factor, nkx-2.5. J. Biol. Chem. 270: 15628-15633.
35. Chen, C. Y., et al. (1996). Activation of the cardiac alpha-actin promoter depends upon serum response factor, Tinman homologue, Nkx-2.5, and intact serum response elements. Dev. Genet. 19: 119-130.
36. Ko, L. J., and Engel, J. D. (1993). DNA-binding specificities of the GATA transcription factor family. Mol. Cell. Biol. 13: 4011-4022.
37. de Jong, R., van der Heijden, J., and Meijlink, F. (1993). DNA-binding specificity of the S8 homeodomain. Nucleic Acids Res. 21: 4711-4720.
38. Tennyson, C. N., Klamut, H. J., and Worton, R. G. (1995). The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced. Nat. Genet. 9: 184-190.
39. Klamut, H. J., Bosnoyan-Collins, L. O., Worton, R. G., Ray, P. N., and Davis, H. L. (1996). Identification of a transcriptional enhancer within muscle intron 1 of the human dystrophin gene. Hum. Mol. Genet. 5: 1599-1606.
40. Klamut, H. J., Bosnoyan-Collins, L. O., Worton, R. G., and Ray, P. N. (1997). A muscle-specific enhancer within intron 1 of the human dystrophin gene is functionally dependent on single MEF-1/E box and MEF-2/AT-rich sequence motifs. Nucleic Acids Res. 25: 1618-1625.
41. Torelli, S., Ferlini, A., Obici, L., Sewry, C., and Muntoni, F. (1999). Expression, regulation and localisation of dystrophin isoforms in human foetal skeletal and cardiac muscle. Neuromusc. Disord. 9: 541-551.
42. Yaffe, D., and Saxel, O. (1977). Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727.
43. Kimes, B. W., and Brandt, B. L. (1976). Properties of a clonal muscle cell line from rat heart. Exp. Cell Res. 98: 367-381.
44. Dostal, D. E., Rothblum, K. N., Chernin, M. I., Cooper, G. R., and Baker, K. M. (1992). Intracardiac detection of angiotensinogen and renin: A localized renin-angiotensin system in neonatal rat heart. Am. J. Physiol. 263: C838-850.